Publications

5804 Results

Novel long-term co-culture approach identifies prognostically important heterogeneity of stem/progenitor cell involvement in human acute myeloid leukemia

Authors
GS Laszlo;JM Lionberger;BS Harrington;CJ Gudgeon;M Othus;F Appelbaum;ID Bernstein;R Walter
Journal / Conference
Blood 122:1318; ASH annual meeting, poster presentaton
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500

Azacitidine with our without entinostat for the treatment of therapy related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Authors
T Prebet;Z Sun;R Ketterling;P Greenberg;A Zeidan;M Litzow;J Gabriolove;H Erba;E Paietta;M Czader;SD Gord;M Tallman
Journal / Conference
Blood 122:3924, ASH annual meeting, poster presentation;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
E1905

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

Authors
R Thariani;NL Henry;S Ramsey;DK Blough;W Barlow;J Gralow;D Veenstra
Journal / Conference
Journal of Comparative Effectiveness Research 2(3):325-334
Year
2013
Research Committee(s)
Breast
PMID
PMID24236631
PMC
PMC4018420
Study Number(s)
S1007

Evaluation of a novel 3 factor prognostic score (PS-3) for patients with advanced Hodgkin lymphoma (HL) treated on US Intergroup E2496

Authors
CS Diefenbach;H Li;LI Gordon;RI Fisher;NL Bartlett;M Crump;RD Gascoyne;H Wagner;P Stiff;B Cheson;D Stewart;B Kahl;J Friedberg;K Blum;T Habermann;JM Tuscano;R Hoppe;SJ Horning;R Advani
Journal / Conference
Blood 122:4277; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E2496

Novel agents for multiple myeloma to overcome resistance in phase III clinical trials

Authors
RZ Orlowski
Journal / Conference
Seminars in Oncology 40(5):634-651
Year
2013
Research Committee(s)
Myeloma
PMID
PMID24135408
PMC
PMC3819933

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial

Authors
JC Boughey;VJ Suman;EA Mittendorf;GM Ahrendt;LG Wilke;B Taback;AM Leitch;HM Kuerer;M Bowling;TS Flippo-Morton;DR Byrd;DW Ollila;TB Julian;SA McLaughlin;L McCall;WF Symmans;HT Le-Petross;BG Haffty;HT Buchholz;H Nelson;KK Hunt
Journal / Conference
Journal of the American Medical Association 310(14):1455-1461
Year
2013
Research Committee(s)
Breast
PMID
PMID24101169
PMC
PMC4075763

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial

Authors
LL Gunderson;J Moughan;JA Ajani;JE Pedersen;KA Winter;AB Benson;CR Thomas;RJ Mayer;MG Haddock;T Rich;CG Willett
Journal / Conference
International Journal of Radiation Oncology, Biology, Physics 87(4):638-645
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID24035327
PMC
PMC3938865
Study Number(s)
R9811

Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design

Authors
MHG Katz;R Marsh;JM Herman;Q Shi;E Collison;AP Venook;HL Kindler;SR Alberts;PA Philip;AM Lowy;PWT Pisters;MC Posner;JD Berlin;SA Ahmad
Journal / Conference
Annals of Surgical Oncology 20(8):2787-2795
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID23435609
PMC
PMC5600517
Study Number(s)
CTSU/A021101

Survival in the prostate cancer prevention trial

Authors
C Tangen;P Goodman;IM Thompson
Journal / Conference
New England Journal of Medicine 369(20):1968
Year
2013
Research Committee(s)
Cancer Control
PMID
PMID24224632
PMC
PMC4927191
Study Number(s)
SWOG-9217

Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer (ES-SCLC): a patients level analysis of SWOG trials

Authors
P Lara;J Moon;M Reddman;K Kelly;J Allen;B Gitlitz;PC Mack;D Gandara
Journal / Conference
Journal of Thoracic Oncology 8(suppl. 2): abstr. MO13.01; the 15th World Conference on Lung Cancer, October 2013, Sydney, Australia
Year
2013
Research Committee(s)
Lung
Study Number(s)
S0327, S0435, S0802